Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indo Komoditi Korpora Tbk. (INCF) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Indo Komoditi Korpora Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Indo Komoditi Korpora Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Indo Komoditi Korpora Tbk. trades at Rp50 (market cap 71.92B), while UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 9.6× Indo Komoditi Korpora Tbk.'s market cap. Which is the better fit depends on your goals.

INCFLABS
Market Cap
71.92B691.25B
Volume
635.5K
Lot
6.36K
Turnover
110.15M
Average Price
173.33
Value
110.15M
Indicative Equilibrium Price
174
Indicative Equilibrium Volume
50

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

INCF
View details
LABS
View details

About Indo Komoditi Korpora Tbk.

PT Indo Komoditi Korpora Tbk (the Company) and its subsidiary (together referred as the "Group"), established in the Republic of Indonesia based on deed of establishment No. 125 dated February 23rd, 1982, made in the presence of Frederik Alexander Tumbuan, S.H., Notary in Jakarta, which the Company was originally named PT Indo Alaya Leasing Corporation.

Read more on INCF

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS